| 1 |
Part II. Eosinophilia-Myalgia Syndrome: further correlations between compromised histamine degradation, eosinophilias and myopathies |
|
| | Smith MJ, Garrett RH | | | INFLAMMATION RESEARCH. 2007; 56: S7-S8 | | | [Pubmed] [Google Scholar] | | | 2 |
Quaternary isoquinoline alkaloids sanguinarine and chelerythrine. In vitro and in vivo effects |
|
| | Zdarilova A, Malikova J, Dvorak Z, Ulrichova J, Simanek V | | | CHEMICKE LISTY. 2006; 100 (1): 30-41 | | | [Pubmed] [Google Scholar] | | | 3 |
Two new protopines argemexicaines A and B and the anti-HIV alkaloid 6-acetonyldihydrochelerythrine from formosan Argemone mexicana |
|
| | Chang YC, Hsieh PW, Chang FR, et al. | | | PLANTA MEDICA. 2003; 69 (2): 148-152 | | | [Pubmed] [Google Scholar] | | | 4 |
Clinicoepidemiological, toxicological, and safety evaluation studies on argemone oil |
|
| | Das M, Khanna SK | | | CRITICAL REVIEWS IN TOXICOLOGY. 1997; 27 (3): 273-297 | | | [Pubmed] [Google Scholar] | | | 5 |
BIOLOGICAL-ACTIVITY OF QUATERNARY BENZO[C] PHENANTHRIDINE ALKALOIDS - SANGUINARINE AND CHELERYTHRINE |
|
| | VAVRECKOVA C, ULRICHOVA J | | | CHEMICKE LISTY. 1994; 88 (4): 238-248 | | | [Pubmed] [Google Scholar] | | | 6 |
PHARMACOLOGICAL ACTIVITIES OF BENZOPHENANTHRIDINE AND PHENANTHRENE ALKALOIDS |
|
| | SIMEON S, RIOS JL, VILLAR A | | | PHARMAZIE. 1989; 44 (9): 593-597 | | | [Pubmed] [Google Scholar] | |
|
